N. Schugardt

An arginine/lysine‐rich motif is crucial for VCP/p97‐mediated modulation of ataxin‐3 fibrillogenesis

S. Plassmann, E. Wanker, J. Suopanki, 2006, The EMBO journal.

Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy.

H. Lehrach, E. Wanker, E. Scherzinger, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay

H. Lehrach, E. Wanker, S. Waelter, 2002, Proceedings of the National Academy of Sciences of the United States of America.